首页> 外文期刊>Journal of cell biology >A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.
【24h】

A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.

机译:酵母Saccharomyces cerevisiae中的一种新的FK506和雷帕霉素结合蛋白(FPR3基因产物)是定位在核仁上的脯氨酸旋转酶。

获取原文
获取外文期刊封面目录资料

摘要

The gene (FPR3) encoding a novel type of peptidylpropyl-cis-trans-isomerase (PPIase) was isolated during a search for previously unidentified nuclear proteins in Saccharomyces cerevisiae. PPIases are thought to act in conjunction with protein chaperones because they accelerate the rate of conformational interconversions around proline residues in polypeptides. The FPR3 gene product (Fpr3) is 413 amino acids long. The 111 COOH-terminal residues of Fpr3 share greater than 40% amino acid identity with a particular class of PPIases, termed FK506-binding proteins (FKBPs) because they are the intracellular receptors for two immunosuppressive compounds, rapamycin and FK506. When expressed in and purified from Escherichia coli, both full-length Fpr3 and its isolated COOH-terminal domain exhibit readily detectable PPIase activity. Both fpr3 delta null mutants and cells expressing FPR3 from its own promoter on a multicopy plasmid have no discernible growth phenotype and do not display any alteration in sensitivity to the growth-inhibitory effects of either FK506 or rapamycin. In S. cerevisiae, the gene for a 112-residue cytosolic FKBP (FPR1) and the gene for a 135-residue ER-associated FKBP (FPR2) have been described before. Even fpr1 fpr2 fpr3 triple mutants are viable. However, in cells carrying an fpr1 delta mutation (which confers resistance to rapamycin), overexpression from the GAL1 promoter of the C-terminal domain of Fpr3, but not full-length Fpr3, restored sensitivity to rapamycin. Conversely, overproduction from the GAL1 promoter of full-length Fpr3, but not its COOH-terminal domain, is growth inhibitory in both normal cells and fpr1 delta mutants. In fpr1 delta cells, the toxic effect of Fpr3 overproduction can be reversed by rapamycin. Overproduction of the NH2-terminal domain of Fpr3 is also growth inhibitory in normal cells and fpr1 delta mutants, but this toxicity is not ameliorated in fpr1 delta cells by rapamycin. The NH2-terminal domain of Fpr3 contains long stretches of acidic residues alternating with blocks of basic residues, a structure that resembles sequences found in nucleolar proteins, including S. cerevisiae NSR1 and mammalian nucleolin. Indirect immunofluorescence with polyclonal antibodies raised against either the NH2- or the COOH-terminal segments of Fpr3 expressed in E. coli demonstrated that Fpr3 is located exclusively in the nucleolus.
机译:在寻找酿酒酵母中先前未鉴定的核蛋白的过程中,分离了编码新型肽基丙基顺-反异构酶(PPIase)的基因(FPR3)。 PPIase被认为与蛋白伴侣一起发挥作用,因为它们加快了多肽中脯氨酸残基周围构象互变的速率。 FPR3基因产物(Fpr3)长413个氨基酸。 Fpr3的111个COOH末端残基与一类称为PK506结合蛋白(FKBPs)的特定PPIase具有超过40%的氨基酸同一性,因为它们是两种免疫抑制化合物雷帕霉素和FK506的细胞内受体。当在大肠杆菌中表达并从大肠杆菌中纯化时,全长Fpr3及其分离的COOH末端结构域均显示出易于检测的PPIase活性。在多拷贝质粒上,fpr3Δnull突变体和从其自身的启动子表达FPR3的细胞都没有可识别的生长表型,并且对FK506或雷帕霉素的生长抑制作用没有任何敏感性的改变。在酿酒酵母中,先前已经描述了具有112个残基的胞质FKBP的基因(FPR1)和具有135个残基的与ER相关的FKBP的基因(FPR2)。甚至fpr1 fpr2 fpr3三重突变体也是可行的。但是,在带有fpr1δ突变的细胞(赋予对雷帕霉素的抗性)中,Fpr3 C末端结构域的GAL1启动子过表达,而全长Fpr3则没有,从而恢复了对雷帕霉素的敏感性。相反,全长Fpr3的GAL1启动子的过量生产,而不是其COOH末端结构域的过量生产,在正常细胞和fpr1 delta突变体中都具有生长抑制作用。在fpr1三角洲细胞中,雷帕霉素可以逆转Fpr3过量产生的毒性作用。 Fpr3的NH2末端结构域的过量生产在正常细胞和fpr1 delta突变体中也具有生长抑制作用,但是雷帕霉素在fpr1 delta细胞中并未改善这种毒性。 Fpr3的NH2末端结构域包含长段的酸性残基,与碱性残基的嵌段交替排列,该结构类似于在核仁蛋白(包括酿酒酵母NSR1和哺乳动物核仁蛋白)中发现的序列。用针对在大肠杆菌中表达的Fpr3的NH2-或COOH末端片段产生的多克隆抗体进行的间接免疫荧光证明Fpr3仅位于核仁中。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号